The Ensign Group (NASDAQ:ENSG) used its fourth-quarter fiscal 2025 earnings call to highlight record full-year and quarterly ...
The fair value estimate for GSK has been nudged to £18.83 from £18.73, a small move that reflects a tug of war between more optimistic price target hikes and ongoing caution around the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results